Why Pacira (PCRX) is Poised to Beat Earnings Estimates Again

Core Insights - Pacira (PCRX) has consistently surpassed earnings estimates, averaging a 7.77% beat over the last two quarters [1] - In the last reported quarter, Pacira achieved earnings of $0.91 per share, exceeding the Zacks Consensus Estimate of$0.86 per share by 5.81% [2] - The previous quarter also saw Pacira outperforming expectations, with actual earnings of $0.79 per share against an estimate of$0.72 per share, resulting in a surprise of 9.72% [2] Earnings Estimates and Predictions - There has been a favorable change in earnings estimates for Pacira, with a positive Zacks Earnings ESP (Expected Surprise Prediction) indicating a strong likelihood of an earnings beat [4] - Stocks with a positive Earnings ESP and a Zacks Rank of 3 (Hold) or better have a nearly 70% chance of producing a positive surprise [5] - Pacira currently has an Earnings ESP of +12.06%, suggesting analysts are optimistic about the company's earnings prospects [7] Importance of Earnings ESP - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, with the Most Accurate Estimate reflecting the latest analyst revisions [6] - A positive Earnings ESP combined with a Zacks Rank 3 indicates a potential earnings beat, while a negative value reduces predictive power but does not guarantee a miss [7] - It is crucial to check a company's Earnings ESP before quarterly releases to enhance the likelihood of successful investment decisions [8]